Discovery of Unique Molecular Pathways in Patients with Lupus Nephritis for the Development of Novel Precision Therapies
Virginia Pascual, Gale and Ira Drukier Director of Children's Health Research, Ronay Menschel Professor of Pediatrics
Developing Drugs for Reversing Hyperglycemia and Insulin Resistance
Khaled Machaca, Senior Associate Dean for Research
Development of a Novel Antioxidant Gene Therapy for the Treatment of Ocular Disorders
Stephen Kaminsky, Professor of Research in Genetic Medicine
Inhibition of Annexin A2 for the Treatment and Prevention of Retinopathies
Katherine Hajjar, Professor of Pediatrics
Novel Ex Vivo Organoid Model Platform for Drug Development in Cancer and Cardiovascular Disease
Olivier Elemento, Director of the Englander Institute for Precision Medicine
Novel Platform for Target Discovery and Validation for Chronic Lung Disease Using Personalized 3D Lung Tissue Units
Renat Shaykhiev, Associate Professor of Medicine
Key Enabling Technology for the Development of Novel Therapeutics for Age-Related Macular Degeneration
Ching-Hwa Sung, The Betty Neuwirth Lee and Chilly Professor in Stem Cell Research
Development of Novel Therapeutics for Chronic Inflammation by Leveraging Innate Lymphocyte Populations
Gregory Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine
Developing Novel First-in-Class Therapeutics for Colorectal Cancer
Gregory Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine
Development of A Novel Multi-functional Compound for the Treatment of Autoimmune Disorders
Laura Santambrogio, Professor of Radiation Oncology